genes and potential cancer therapy

RAS is one of the most commonly mutated gene families in human cancers – one of its three members (KRAS, HRAS and NRAS) is mutated in about 20% of human tumours. Attempts to target mutant RAS proteins directly with small-molecule inhibitors have so far proved unsuccessful, so there has been considerable interest in finding signalling…

Read more
Back to top